1. Clark, A. C., The need for new antifungal drugs, in Fernandes, P.B. (Eds.).New Approaches for Antifungal Drugs. Birkhaeser, Boston, pp. 1–19, 1992.
2. Fisher, M. A., Lee, P. G. and Tarry W. F., Fluconazole treatment of candidiasis in normal and diabetic rats.Antimicrob. Agents Chemother., 33, 1042–1045 (1989).
3. Georgopapadakou, N. H. and Walsh, J., Human mycoses: Drugs and targets for emerging pathogens.Science, 264, 371–373 (1994).
4. Hudson, A. T., Atovaquone-A novel agent for the treatment of malaria, PCP and toxoplasmosis. in Bentley, P. H. and Ponsford, R. (Eds.).Recent Advances in the Chemistry of Anti-infective Agents. Royal Society of Chemistry, Cambridge, pp. 322–335, 1992.
5. Jeschke, P., Linder, W., Mueller, N. and Dehne, H. W., Fungicides based on amino-substituted quinoline-quinones. Ger. Offen., DE 4,208,874 (1993).